Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00005808 · ClinicalTrials.gov registry record · Phase 1
Photodynamic Therapy Using Lutetium Texaphyrin in Treating Patients With Cervical Intraepithelial Neoplasia
A Phase 1 study, sponsored by National Cancer Institute (NCI).
- Terminated
- Registry status
- Phase 1
- Development phase
- 54
- Enrollment target
NCT00005808: Clinical Trial Phase 1 study, sponsored by National Cancer Institute (NCI).
NCT00005808 is a Phase 1 study that was terminated before completion, run by National Cancer Institute (NCI). The registered enrollment target is 54 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00005808, a Phase 1 study, was terminated before completion, sponsored by National Cancer Institute (NCI).
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 54 participants
- Enrollment target
Study Summary
Phase I trial to study the effectiveness of photodynamic therapy with lutetium texaphyrin in treating patients who have cervical intraepithelial neoplasia. Photodynamic therapy uses light and drugs such as lutetium texaphyrin that make abnormal cells more sensitive to light and may kill abnormal cells in the cervix and prevent the development of cervical cancer
Interventions
- OTHER laboratory biomarker analysis
- DRUG photodynamic therapy
- DRUG motexafin lutetium
- PROCEDURE loop electrosurgical excision procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2000-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00005808
The ClinicalTrials.gov registry entry for NCT00005808 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which laboratory biomarker analysis is the first listed.
NCT00005808 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00005808 about?
NCT00005808 is a clinical study titled "Photodynamic Therapy Using Lutetium Texaphyrin in Treating Patients With Cervical Intraepithelial Neoplasia". Phase I trial to study the effectiveness of photodynamic therapy with lutetium texaphyrin in treating patients who have cervical intraepithelial neoplasia. Photodynamic therapy uses light and drugs such as lutetium texaphyrin that make abnormal cells more sensitive to light and may kill abnormal cel...
What is the current status of trial NCT00005808?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 54 participants. The study started on 2000-12.
What interventions are being tested in trial NCT00005808?
The interventions under investigation include: laboratory biomarker analysis (OTHER), photodynamic therapy (DRUG), motexafin lutetium (DRUG), loop electrosurgical excision procedure (PROCEDURE).
Who is sponsoring clinical trial NCT00005808?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.